Ludvig M Sollid Selected Research

Glutens (Glutelin)

1/2022	Transglutaminase 2 affinity and enzyme-substrate intermediate stability as determining factors for T-cell responses to gluten peptides in celiac disease.
1/2022	Structural basis of T cell receptor specificity and cross-reactivity of two HLA-DQ2.5-restricted gluten epitopes in celiac disease.
1/2022	Phenotype-Based Isolation of Antigen-Specific CD4+ T Cells in Autoimmunity: A Study of Celiac Disease.
1/2022	Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy.
11/2021	Pathogenic T Cells in Celiac Disease Change Phenotype on Gluten Challenge: Implications for T-Cell-Directed Therapies.
2/2021	In Well-Treated Celiac Patients Low-Level Mucosal Inflammation Predicts Response to 14-day Gluten Challenge.
1/2021	A high-affinity human TCR-like antibody detects celiac disease gluten peptide-MHC complexes and inhibits T cell activation.
1/2021	Frequency of Gluten-Reactive T Cells in Active Celiac Lesions Estimated by Direct Cell Cloning.
1/2021	Response to: "Some considerations about γδ and CD8+ T-cell responses in blood after gluten challenge in treated celiac disease".
1/2021	Machine Learning Analysis of Naïve B-Cell Receptor Repertoires Stratifies Celiac Disease Patients and Controls.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ludvig M Sollid Research Topics

Disease

123	Celiac Disease (Celiac Sprue) 09/2022 - 09/2002
12	Inflammation (Inflammations) 02/2021 - 08/2003
6	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2002
5	Immune System Diseases (Immune Disorders) 01/2021 - 01/2005
5	Rheumatoid Arthritis 07/2012 - 04/2006
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 07/2012
3	Atrophy 01/2021 - 10/2004
2	Multiple Sclerosis 01/2022 - 07/2012
2	Infections 11/2021 - 01/2017
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2019
1	Autoimmune enteropathy 01/2022
1	Disease Susceptibility (Diathesis) 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Human Influenza (Influenza) 01/2019
1	Systemic Scleroderma (Systemic Sclerosis) 01/2019
1	Wounds and Injuries (Trauma) 01/2018
1	Food Hypersensitivity (Food Allergy) 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Crohn Disease (Crohn's Disease) 11/2015
1	Hypersensitivity (Allergy) 08/2011
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2011
1	Virus Diseases (Viral Diseases) 01/2011
1	Ataxia (Dyssynergia) 11/2010
1	Dermatitis Herpetiformis (Disease, Duhring's) 11/2010
1	Intestinal Diseases (Diseases, Intestinal) 12/2009
1	Neoplasms (Cancer) 07/2006
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2005
1	Tetraploidy 02/2005
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2003

Drug/Important Bio-Agent (IBA)

95	Glutens (Glutelin)IBA 01/2022 - 09/2002
43	Peptides (Polypeptides)IBA 01/2022 - 09/2002
33	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2022 - 09/2002
26	EpitopesIBA 01/2022 - 03/2004
20	EnzymesIBA 01/2022 - 09/2002
20	AntigensIBA 01/2022 - 12/2005
19	AutoantibodiesIBA 01/2020 - 09/2002
14	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 11/2019 - 09/2002
13	AntibodiesIBA 09/2022 - 04/2004
13	HLA-DQ Antigens (HLA-DQ)IBA 01/2022 - 04/2003
11	GliadinIBA 01/2022 - 09/2002
11	AutoantigensIBA 01/2020 - 09/2002
11	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2003
9	Immunoglobulin A (IgA)IBA 09/2022 - 12/2005
9	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 02/2006
6	TransglutaminasesIBA 04/2019 - 04/2009
5	Immunoglobulin G (IgG)IBA 09/2022 - 12/2005
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2017
4	CytokinesIBA 01/2019 - 03/2005
4	Peptide Hydrolases (Proteases)FDA Link 08/2014 - 09/2002
4	Proline (L-Proline)FDA Link 07/2005 - 03/2004
3	Monoclonal AntibodiesIBA 01/2016 - 12/2014
3	HLA-DQ8 antigenIBA 02/2012 - 08/2006
2	KIR ReceptorsIBA 01/2022 - 12/2021
2	Peptide FragmentsIBA 01/2016 - 11/2010
2	Protein Isoforms (Isoforms)IBA 05/2012 - 02/2009
2	Indicators and Reagents (Reagents)IBA 06/2011 - 02/2007
2	LigandsIBA 02/2006 - 03/2005
2	ProlaminsIBA 10/2004 - 10/2004
2	HLA-DQA1 antigen (HLA DQA1)IBA 04/2003 - 03/2003
1	Formaldehyde (Formol)FDA Link 02/2021
1	ProteomeIBA 02/2021
1	ParaffinIBA 02/2021
1	ChromatinIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Histocompatibility Antigens Class IIIBA 01/2021
1	SuspensionsIBA 04/2019
1	Hemagglutinins (Hemagglutinin)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Extracellular Matrix ProteinsIBA 06/2015
1	SolutionsIBA 12/2014
1	Multifunctional EnzymesIBA 12/2014
1	DeuteriumIBA 12/2014
1	HydrogenIBA 12/2014
1	Protein-Arginine DeiminasesIBA 05/2012
1	Aspartic Acid (Aspartate)FDA Link 04/2012
1	HLA-DQ9 antigenIBA 04/2012
1	Pharmaceutical PreparationsIBA 01/2012
1	Histocompatibility Antigens (Histocompatibility Antigen)IBA 10/2009
1	Biomarkers (Surrogate Marker)IBA 08/2009
1	A-factor (Streptomyces)IBA 04/2009
1	CitrullineIBA 05/2006
1	myosin IXBIBA 04/2006
1	Glutamine (L-Glutamine)FDA Link 07/2005
1	Glutamic Acid (Glutamate)FDA Link 07/2005
1	ElementsIBA 06/2005
1	Biological ProductsIBA 02/2005
1	Histamine (Histamine Dihydrochloride)FDA Link 02/2005
1	EndopeptidasesIBA 10/2004
1	Chromogenic CompoundsIBA 10/2004
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 03/2003
1	Prolyl OligopeptidasesIBA 09/2002

Therapy/Procedure

7	Therapeutics 11/2021 - 09/2002
6	Gluten-Free Diet 02/2021 - 10/2004
1	Precision Medicine 11/2021
1	Immunotherapy 11/2021
1	Pancreaticoduodenectomy 04/2019